NO960723D0 - Inhibitors of TNF-alpha secretion - Google Patents
Inhibitors of TNF-alpha secretionInfo
- Publication number
- NO960723D0 NO960723D0 NO960723A NO960723A NO960723D0 NO 960723 D0 NO960723 D0 NO 960723D0 NO 960723 A NO960723 A NO 960723A NO 960723 A NO960723 A NO 960723A NO 960723 D0 NO960723 D0 NO 960723D0
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- inhibitors
- alpha secretion
- secretion
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11060193A | 1993-08-23 | 1993-08-23 | |
US18301994A | 1994-01-18 | 1994-01-18 | |
PCT/US1994/009343 WO1995006031A1 (en) | 1993-08-23 | 1994-08-19 | Inhibitors of tnf-alpha secretion |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960723D0 true NO960723D0 (en) | 1996-02-23 |
NO960723L NO960723L (en) | 1996-02-23 |
Family
ID=26808203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960723A NO960723L (en) | 1993-08-23 | 1996-02-23 | Inhibitors of TNF-alpha secretion |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0715619A4 (en) |
JP (1) | JPH09503201A (en) |
AU (2) | AU687436B2 (en) |
CA (1) | CA2170158A1 (en) |
FI (1) | FI960803A (en) |
NO (1) | NO960723L (en) |
NZ (1) | NZ271893A (en) |
WO (1) | WO1995006031A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69509401T2 (en) * | 1994-10-05 | 1999-08-19 | Darwin Discovery Ltd. | PEPTIDIC COMPOUNDS AND THEIR THERAPEUTIC USE AS METALLOPROTEINASE INHIBITORS |
WO1996035714A1 (en) * | 1995-05-10 | 1996-11-14 | Chiroscience Limited | Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
US5981491A (en) * | 1995-05-10 | 1999-11-09 | Darwin Discovery Limited | Peptidyl compounds and their therapeutic use |
EP0824544B1 (en) * | 1995-05-10 | 2003-04-16 | Darwin Discovery Limited | Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
US6406901B1 (en) | 1995-06-08 | 2002-06-18 | Immunex Corporation | TNF-a converting enzyme |
US5883241A (en) * | 1995-09-05 | 1999-03-16 | Celltech Therapeutics Limited | DNA sequences coding for a human metalloproteinase and variants thereof |
AU710072B2 (en) * | 1995-10-05 | 1999-09-16 | Darwin Discovery Limited | Thio-substituted peptides as inhibitors for metalloproteinases and TNF liberation |
US5665777A (en) * | 1995-11-14 | 1997-09-09 | Abbott Laboratories | Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
HUP9903863A3 (en) | 1995-11-23 | 2000-11-28 | British Biotech Pharm | Metalloproteinase inhibitors |
GB9607120D0 (en) * | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
US5990293A (en) * | 1996-09-05 | 1999-11-23 | Celltech Therapeutics Limited | Human metalloproteinase, variants thereof and DNA sequence coding therefor |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
EP0925278B1 (en) | 1996-09-10 | 2002-07-17 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
ZA9818B (en) * | 1997-01-07 | 1998-07-02 | Abbott Lab | C-terminal ketone inhibitors of matrix metalloproteinases and tnf alpha secretion |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
CA2295440A1 (en) * | 1997-06-18 | 1998-12-23 | The Rockefeller University | Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
JP2001519381A (en) * | 1997-10-10 | 2001-10-23 | インペリアル・カレッジ・イノベイションズ・リミテッド | Use of CSAID ™ compounds for management of uterine contractions |
GB9810464D0 (en) * | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
GB9818605D0 (en) | 1998-08-26 | 1998-10-21 | Glaxo Group Ltd | Formamide compounds as therepeutic agents |
US6172064B1 (en) | 1998-08-26 | 2001-01-09 | Glaxo Wellcome Inc. | Formamides as therapeutic agents |
US6329400B1 (en) | 1998-08-26 | 2001-12-11 | Glaxo Wellcome Inc. | Formamide compounds as therapeutic agents |
BR9914196A (en) * | 1998-09-30 | 2001-06-19 | Procter & Gamble | Hair loss treatment process |
AU6060299A (en) * | 1998-09-30 | 2000-04-17 | Procter & Gamble Company, The | Method of treating hair loss using ketoamides |
US6300341B1 (en) | 1998-09-30 | 2001-10-09 | The Procter & Gamble Co. | 2-substituted heterocyclic sulfonamides |
US6307049B1 (en) | 1998-09-30 | 2001-10-23 | The Procter & Gamble Co. | Heterocyclic 2-substituted ketoamides |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
US6329550B1 (en) | 1998-12-31 | 2001-12-11 | Aventis Pharmaceuticals Inc. | Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase |
CN1342078A (en) * | 1999-01-13 | 2002-03-27 | 朱马制药有限公司 | Use of 3-isoxazolidinones and hydroxylamine acids for treatment of infections |
US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
GB9922825D0 (en) * | 1999-09-25 | 1999-11-24 | Smithkline Beecham Biolog | Medical use |
AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
WO2002028829A2 (en) * | 2000-09-25 | 2002-04-11 | Questcor Pharmaceuticals, Inc. | Peptide deformylase inhibitors |
PE20030701A1 (en) | 2001-12-20 | 2003-08-21 | Schering Corp | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS |
EP3860608A1 (en) | 2018-10-04 | 2021-08-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Egfr inhibitors for treating keratodermas |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0207097B1 (en) * | 1984-12-19 | 1990-08-08 | Ciba-Geigy Ag | New carbonic acid esters |
FR2609289B1 (en) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | NOVEL COMPOUNDS HAVING ACTIVITY OF COLLAGENASE INHIBITORS, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
WO1992022523A2 (en) * | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
-
1994
- 1994-08-19 EP EP94925940A patent/EP0715619A4/en not_active Ceased
- 1994-08-19 CA CA002170158A patent/CA2170158A1/en not_active Abandoned
- 1994-08-19 AU AU75694/94A patent/AU687436B2/en not_active Ceased
- 1994-08-19 WO PCT/US1994/009343 patent/WO1995006031A1/en not_active Application Discontinuation
- 1994-08-19 JP JP7507668A patent/JPH09503201A/en active Pending
- 1994-08-19 NZ NZ271893A patent/NZ271893A/en unknown
-
1996
- 1996-02-22 FI FI960803A patent/FI960803A/en unknown
- 1996-02-23 NO NO960723A patent/NO960723L/en unknown
-
1998
- 1998-01-06 AU AU50302/98A patent/AU5030298A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0715619A4 (en) | 1997-03-19 |
NO960723L (en) | 1996-02-23 |
EP0715619A1 (en) | 1996-06-12 |
AU687436B2 (en) | 1998-02-26 |
JPH09503201A (en) | 1997-03-31 |
WO1995006031A1 (en) | 1995-03-02 |
FI960803A0 (en) | 1996-02-22 |
AU7569494A (en) | 1995-03-21 |
CA2170158A1 (en) | 1995-03-02 |
FI960803A (en) | 1996-04-22 |
NZ271893A (en) | 1997-11-24 |
AU5030298A (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO960723D0 (en) | Inhibitors of TNF-alpha secretion | |
NO932620D0 (en) | AMINDIOL protease inhibitors | |
CY2164B1 (en) | Sulfonamide inhibitors of hiv-aspartyl protease | |
PL331856A1 (en) | Heterocyclic inhibitors of metaloprotease | |
DK42093D0 (en) | METHOD OF ADMINISTRATION | |
NO990548D0 (en) | Inhibitors of cysteine protease | |
KR950702629A (en) | BANDAGE FOR CONTINUOUS APPLICATION OF BIOLOGICALS | |
NO981938D0 (en) | protease inhibitors | |
NO954427D0 (en) | HIV protease inhibitors useful for the treatment of AIDS | |
ZA939285B (en) | Inhibitors of aspartyl protease | |
NO941181D0 (en) | Heterocyclic inhibitors of farnesyl protein transferase | |
NO962269D0 (en) | Enzyme inhibitors | |
DK0505222T3 (en) | Method of freezing | |
FI943234A0 (en) | Human Kunitzt type protease inhibitor variant | |
FI954119A (en) | Procedure for the treatment of solid waste | |
PL328665A1 (en) | Inhibitors of serinic protease | |
AU2251892A (en) | Inhibitors of picornavirus proteases | |
FI935644A (en) | Retroviral protease inhibitors | |
NO985214D0 (en) | Inhibitors for production of s-CD23 and secretion of TNF | |
FI921059A (en) | Method for secretion of useful proteins from yeasts | |
FI964342A0 (en) | Halomethylamides as IL-1beta protease inhibitors | |
DK0623614T3 (en) | 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as inhibitors of 5-lipoxygenase | |
FI925144A (en) | The use of inhibitors for the production of chromogens and the addition of chromogens | |
NO180704B (en) | Method of expansion of tobacco | |
MX9100121A (en) | ASPARTICAL PROTEASE INHIBITORS |